Vimarsana
Biggest News Aggregation in the World

Page 18 - 46433010 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 46433010. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 46433010 Today - Breaking & Trending Today

CIBC Asset Management Inc Purchases Shares of 5,583 Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) - Vimarsana News

CIBC Asset Management Inc Purchases Shares of 5,583 Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)

CIBC Asset Management Inc purchased a new position in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) in the 1st quarter, HoldingsChannel.com reports. The institutional investor purchased 5,583 shares of the company’s stock, valued at approximately $207,000. A number of other hedge funds and other institutional investors have also recently modified their holdings of […]

$145.04 Million in Sales Expected for Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) This Quarter - Vimarsana News

$145.04 Million in Sales Expected for Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) This Quarter

Wall Street analysts forecast that Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) will post sales of $145.04 million for the current fiscal quarter, according to Zacks. Eight analysts have made estimates for Ionis Pharmaceuticals’ earnings, with the lowest sales estimate coming in at $107.00 million and the highest estimate coming in at $193.90 million. Ionis […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Expected to Announce Earnings of -$0.62 Per Share - Vimarsana News

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Expected to Announce Earnings of -$0.62 Per Share

Wall Street brokerages forecast that Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) will report earnings per share (EPS) of ($0.62) for the current fiscal quarter, according to Zacks. Eight analysts have made estimates for Ionis Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.77) and the highest estimate coming in at ($0.31). Ionis […]

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Average Recommendation of "Hold" by Brokerages - Vimarsana News

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Average Recommendation of "Hold" by Brokerages

Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) have been assigned an average recommendation of “Hold” from the twelve brokerages that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and five have issued a buy rating […]

Ionis Pharmaceuticals (NASDAQ:IONS) Upgraded by StockNews.com to "Buy" - Vimarsana News

Ionis Pharmaceuticals (NASDAQ:IONS) Upgraded by StockNews.com to "Buy"

StockNews.com upgraded shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) from a hold rating to a buy rating in a research report report published on Thursday morning. Several other equities research analysts also recently weighed in on IONS. Bank of America downgraded shares of Ionis Pharmaceuticals from a buy rating to an underperform rating and […]